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Introduction {#sec001}
============

Infection by *Mycoplasma synoviae* occurs worldwide leading to respiratory diseases and synovitis in chickens and turkeys, and eggshell apex abnormality in chickens, and as a consequence to high economic losses in the poultry industry \[[@pone.0175969.ref001]--[@pone.0175969.ref003]\]. The severity of clinical signs can vary from sub-clinical to severe forms and it depends on the pathogenicity of the agent and on the presence of other bacteria or viruses (e.g. *Escherichia coli* or infectious bronchitis virus) \[[@pone.0175969.ref001]--[@pone.0175969.ref002],[@pone.0175969.ref004]\]. *M*. *synoviae* can be transmitted horizontally, colonizing first the respiratory tract or vertically through the eggs \[[@pone.0175969.ref004]--[@pone.0175969.ref006]\]. To prevent the introduction of *M*. *synoviae* into a flock effective biosecurity programs should be applied and mycoplasma-free sources should be used for restocking. Medication can reduce the economic losses in the infected flocks and inhibit the transmission through the eggs \[[@pone.0175969.ref006]\]. Vaccination is another option to control the disease, especially in commercial layers \[[@pone.0175969.ref006]--[@pone.0175969.ref007]\]. At present, two commercial attenuated live vaccines are available against *M*. *synoviae*: the temperature sensitive (ts^+^) MS-H vaccine strain (Vaxsafe® MS, Bioproperties Pty Ltd.) which was developed by the chemical mutagenesis of an Australian field strain (86079/7NS); and the NAD independent MS1 vaccine strain (Nobilis® MS Live, MSD Animal Health Inc.) which was obtained spontaneously during *in vitro* passages of the type strain (WVU 1853, ATCC 25204, NCTC 10124) \[[@pone.0175969.ref008]--[@pone.0175969.ref009]\]. Differentiation of vaccine and wild strains is crucial in the control programs. Several molecular techniques are available for the discrimination of the ts^+^ MS-H strain, its ts^-^ re-isolates and field isolates, such as the sequence analysis of the *vlhA* gene or identification of specific point mutations in the *obg* gene by high resolution melting-curve (HRM) analysis or mismatch amplification mutation assays (MAMAs) \[[@pone.0175969.ref010]--[@pone.0175969.ref012]\]. The comparison of the whole genomes of the WVU 1853 parent strain and the MS1 vaccine strain revealed a single nucleotide polymorphism (SNP) in the histidine triad motif (HIT) family protein coding gene \[[@pone.0175969.ref009]\]. The present study provides melt-curve and agarose-gel based MAMAs specific for the SNP in the HIT family protein coding gene to discriminate MS1 vaccine and field strains. The assays were developed to be used simultaneously with the previously described MS-H1 and MS-H2 MAMAs \[[@pone.0175969.ref012]\], hence differentiating the MS1 vaccine, ts^+^ MS-H vaccine, ts^-^ MS-H vaccine re-isolate and field strains in one simple and cost-efficient step.

Methods {#sec002}
=======

Samples {#sec003}
-------

The vaccine strains MS1 (Nobilis® MS Live) and the ts^+^ MS-H (Vaxsafe® MS-H) used during the examinations originated from their commercial distributors. *M*. *synoviae* (WVU 1835, ATCC 25204, NCTC 10124) type strain was used as control in the assays. *M*. *anatis* (ATCC 25524), *M*. *anseris* (ATCC 49234), *M*. *cloacale* (ATCC 35276), *M*. *columbinasale* (ATCC 33549), *M*. *columbinum* (ATCC 29257), *M*. *columborale* (ATCC 29258), *M*. *gallinaceum* (ATCC 33550), *M*. *gallinarum* (ATCC 19708), *M*. *gallisepticum* (ATCC 19610), *M*. *gallopavonis* (ATCC 33551), *M*. *iners* (ATCC 19705), *M*. *iowae* (ATCC 33552) and *M*. *meleagridis* (NCTC 10153) type strains and a *M*. sp. 1220 strain isolated by the authors were used for the examinations of cross-reactions. The *M*. sp. 1220 strain originated from a cloaca swab of a goose sampled during routine diagnostic examinations in 2016 in Csongrád county, Hungary.

A total of 27 bacterial strains (including a ts^-^ MS-H vaccine re-isolate and 26 *M*. *synoviae* wild-type strains) were collected and isolated by the authors during routine diagnostic examinations of live animals ([Table 1](#pone.0175969.t001){ref-type="table"}). For the validation of the assays, clinical samples including trachea swabs, trachea tissue samples and sample collection cards (Whatman FTA card, Whatman, Maidstone, UK) were collected from vaccinated (160 chickens) and clinically infected (seropositive) chickens and turkeys (total of 59 animals; [Table 1](#pone.0175969.t001){ref-type="table"}). Ethical approval and specific permission were not required for the study as all samples and strains were collected by the authors during routine diagnostic examinations with the consent of the owners. Trachea swabs originated from live animals, tissue samples and FTA cards originated from animals found dead in the farms. The study did not involve endangered or protected animals.

10.1371/journal.pone.0175969.t001

###### Background information and genotype of the *Mycoplasma synoviae* strains and clinical samples included in this study.

![](pone.0175969.t001){#pone.0175969.t001g}

  Sample ID[^a^](#t001fn001){ref-type="table-fn"}   Sample type                     Host[^b^](#t001fn002){ref-type="table-fn"}   Age of host (weeks)   Type of host   Origin of sample[^c^](#t001fn003){ref-type="table-fn"}   Year   Gt[^d^](#t001fn004){ref-type="table-fn"}   Reference
  ------------------------------------------------- ------------------------------- -------------------------------------------- --------------------- -------------- -------------------------------------------------------- ------ ------------------------------------------ --------------------------------------------
  MS1v                                              MS1 vaccine strain                                                                                                Nobilis® MS Live, MSD Animal Health                             MS1                                        
  MS ref                                            *M*. *synoviae* type strain                                                                                       WVU 1853, ATCC25204, NCTC10124                                  Wt                                         
  ts^+^ MS-H                                        ts^+^ MS-H vaccine strain                                                                                         Vaxsafe® MS, Bioproperties Pty Ltd.                             Wt                                         
  ts^-^ MS-H                                        ts^-^ MS-H vaccine re-isolate   ch                                           73                    layer          farm1, Jász-Nagykun-Szolnok, Hungary                     2015   Wt                                         
  MS 1                                              *M*. *synoviae* strain          ch                                                                                USA                                                      1990   Wt                                         K3009/70 \[[@pone.0175969.ref010]\]
  MS 2                                              *M*. *synoviae* strain          ch                                                                                Slovenia                                                 2002   Wt                                         ULB02/T6 \[[@pone.0175969.ref013]\]
  MS 3                                              *M*. *synoviae* strain          ch                                                                                Slovenia                                                 2008   Wt                                         ULB08/T3 \[[@pone.0175969.ref014]\]
  MS 4                                              *M*. *synoviae* strain          ch                                           36                    layer          farm2, Nógrád, Hungary                                   2014   Wt                                         
  MS 5                                              *M*. *synoviae* strain          ch                                           35                    breeder        farm3, Veszprém, Hungary                                 2015   Wt                                         
  MS 6                                              *M*. *synoviae* strain          ch                                           38                    breeder        farm4, Jász-Nagykun-Szolnok, Hungary                     2015   Wt                                         
  MS 7                                              *M*. *synoviae* strain          ch                                           7                     broiler        farm5, Komárom-Esztergom, Hungary                        2015   Wt                                         
  MS 8                                              *M*. *synoviae* strain          ch                                           65                    layer          farm6, Borsod-Abaúj-Zemplén, Hungary                     2015   Wt                                         
  MS 9                                              *M*. *synoviae* strain          ch                                           47                    breeder        farm7, Zala, Hungary                                     2015   Wt                                         
  MS10                                              *M*. *synoviae* strain          ch                                           64                    layer          farm8, Pardubice, Czech Republic                         2015   Wt                                         
  MS 11                                             *M*. *synoviae* strain          ch                                           28                    layer          farm9, Oryol, Russia                                     2015   Wt                                         
  MS 12                                             *M*. *synoviae* strain          ch                                           4                     layer          farm10, Cherkasy, Ukraine                                2015   Wt                                         
  MS 13                                             *M*. *synoviae* strain          ch                                           48                    layer          farm11, Fejér, Hungary                                   2016   Wt                                         
  MS 14                                             *M*. *synoviae* strain          ch                                           30                    layer          farm12, South Moravia, Czech Republic                    2016   Wt                                         
  MS 15                                             *M*. *synoviae* strain          ch                                           45                    breeder        farm13, Serbia                                           2016   Wt                                         
  MS 16                                             *M*. *synoviae* strain          t                                                                                 USA                                                      1983   Wt                                         K1968/clone ZC3 \[[@pone.0175969.ref010]\]
  MS 17                                             *M*. *synoviae* strain          t                                            16                    broiler        farm14, Győr-Moson-Sopron, Hungary                       2014   Wt                                         
  MS 18                                             *M*. *synoviae* strain          t                                            14                    broiler        farm15, Vas, Hungary                                     2014   Wt                                         
  MS 19                                             *M*. *synoviae* strain          t                                            11                    broiler        farm16, Győr-Moson-Sopron, Hungary                       2014   Wt                                         
  MS 20                                             *M*. *synoviae* strain          t                                            13                    broiler        farm17, Békés, Hungary                                   2015   Wt                                         
  MS 21                                             *M*. *synoviae* strain          t                                            13                    broiler        farm18, Komárom-Esztergom, Hungary                       2016   Wt                                         
  MS 22                                             *M*. *synoviae* strain          t                                            16                    broiler        farm19, Győr-Moson-Sopron, Hungary                       2016   Wt                                         
  MS 23                                             *M*. *synoviae* strain          t                                            17                    broiler        farm20, Tolna, Hungary                                   2016   Wt                                         
  MS 24                                             *M*. *synoviae* strain          t                                            20                    broiler        farm21, Veszprém, Hungary                                2016   Wt                                         
  MS 25                                             *M*. *synoviae* strain          t                                            19                    broiler        farm22, Veszprém, Hungary                                2016   Wt                                         
  MS 26                                             *M*. *synoviae* strain          t                                            13                    broiler        farm23, Somogy, Hungary                                  2016   Wt                                         
  TI 1                                              tissue from infected animal     ch                                           48                    breeder        farm24, Pest, Hungary                                    2016   Wt                                         
  TI 2                                              tissue from infected animal     ch                                           34                    layer          farm25, Ternopil, Ukraine                                2016   Wt                                         
  FI 1                                              FTA card from infected animal   ch                                           34                    layer          farm25, Ternopil, Ukraine                                2016   Wt                                         
  FI 2                                              FTA card from infected animal   ch                                           40                    layer          farm25, Ternopil, Ukraine                                2016   Wt                                         
  SI 1--5 (1)                                       swabs from infected animals     ch                                           54                    breeder        farm26, Pest, Hungary                                    2015   Wt                                         
  SI 6--10 (1)                                      swabs from infected animals     ch                                           25                    layer          farm27, Borsod-Abaúj-Zemplén, Hungary                    2016   Wt                                         
  SI 11--15 (1)                                     swabs from infected animals     ch                                           30                    layer          farm28, Hajdú-Bihar, Hungary                             2016   Wt                                         
  SI 16--20 (1)                                     swabs from infected animals     ch                                           24                    layer          farm29, Oryol, Russia                                    2016   Wt                                         
  SI 21--25 (1)                                     swabs from infected animals     t                                            47                    layer          farm30, Vas, Hungary                                     2016   Wt                                         
  SI 26--30 (1)                                     swabs from infected animals     t                                            20                    broiler        farm35, Győr-Moson-Sopron, Hungary                       2016   Wt                                         
  SI 30--35 (1)                                     swabs from infected animals     t                                            18                    broiler        farm16, Győr-Moson-Sopron, Hungary                       2016   Wt                                         
  SI 36--40 (1)                                     swabs from infected animals     t                                            11                    broiler        farm36, Hajdú-Bihar, Hungary                             2016   Wt                                         
  SI 41--45 (1)                                     swabs from infected animals     t                                            18                    broiler        farm37, Komárom-Esztergom, Hungary                       2016   Wt                                         
  SI 46--50 (1)                                     swabs from infected animals     t                                            16                    broiler        farm38, Burgenland, Austria                              2016   Wt                                         
  SI 51--55 (1)                                     swabs from infected animals     t                                            17                    broiler        farm39, Burgenland, Austria                              2016   Wt                                         
  SV 1--30 (6)                                      swabs from vaccinated animals   ch                                           28                    breeder        farm3, Veszprém,Hungary                                  2016   MS1                                        
  SV 31--70 (8)                                     swabs from vaccinated animals   ch                                           29                    breeder        farm40, Veszprém,Hungary                                 2016   MS1                                        
  SV 71--100 (6)                                    swabs from vaccinated animals   ch                                           14                    breeder        farm41, Veszprém,Hungary                                 2016   MS1                                        
  SV 100--160 (12)                                  swabs from vaccinated animals   ch                                           28                    breeder        farm42, Baranya, Hungary                                 2016   MS1                                        

^a^DNA from swab samples were gained in DNA pools (each pool contained 5 swabs); numbers in brackets represent the number of DNA pools examined

^b^all samples were collected from the trachea of the animals; ch: chicken, t: turkey

^c^farm, region and country of origin of the samples

^d^Gt: genotype according to the MS1 DIVA-test; Wt: wild-type, MS1: MS1 vaccine, -: negative

DNA was extracted from the strains, trachea swabs (in DNA pools, each containing 5 trachea swabs), tissue samples and FTA cards with the Qiamp DNA Mini kit (Qiagen GmbH, Hilden, Germany). The ts^-^ MS-H re-isolate was identified by the MS-H1 and MS-H2 MAMAs, based on the point mutations at nt367 (G) and nt629 (C) in the *obg* gene \[[@pone.0175969.ref012]\].

Sequence analysis {#sec004}
-----------------

The HIT family protein coding gene of the MS1 strain was amplified by conventional PCR using the primers MS-HL1 (`5’–ACT GTA AAT GAC GCC TTT TCT AC– 3’`) and MS-HL2 (`5’–ACC GCT TAT GCA AGT AAA TTA TT– 3’`), designed in the present study. The reaction mixture contained 5 μl 5X Green GoTaq Flexi Buffer (Promega Inc., Madison, WI), 2.5 μl MgCl~2~ (25mM, Promega), 0.5 μl dNTP (10 mM, Qiagen Inc., Valencia, CA), 1 μl of each primer (10 pmol/μl), 0.25 μl GoTaq DNA polymerase (5 U/μl; Promega) and 2 μl of target DNA in a total volume of 25 μl. Thermocycling parameters consisted of 95°C for 2 min, then 40 cycles of 95°C for 30sec, 55°C for 30 sec and 72°C for 1 min and a final elongation step at 72°C for 5 min. The amplicons were visualised in 1% agarose gel (Seakem Agarose, Lonza Group Ltd., Basel, Switzerland) under UV light. The amplicons were extracted from the gel using the QIAquick Gel Extraction kit (Qiagen) and submitted for Sanger sequencing on an ABI 3700 DNA Analyzer (Applied Biosystems, Foster City, CA). Sequence of the amplicon of the MS1 strain (660 bp) contains the complete sequence of the HIT family protein coding gene (321 bp) and fragments of the flanking regions (GenBank accession number: KY712765). Alignment of the sequences of the HIT family protein coding genes of the *M*. *synoviae* type strain (ATCC 25204, GenBank Accession Number: CP011096, region (complement): 195625--195945) and the MS1 strain (KY712765) revealed a point mutation at nucleotide (nt) 11 in accordance with the previous publication \[[@pone.0175969.ref009]\]. The described TCA (Ser) / TAA (stop codon) polymorphism results a stop codon in the MS1 vaccine strain ([Fig 1](#pone.0175969.g001){ref-type="fig"}).

![Sequence alignment of the HIT family protein coding gene of the MS1 vaccine strain and its parent strain ATCC 25204.\
Nucleotide polymorphism at 11. position (red) results in premature stop codon in strain MS1.](pone.0175969.g001){#pone.0175969.g001}

Development of mismatch amplification mutation assays {#sec005}
-----------------------------------------------------

MAMA is based on allele-specific competing primers and is used widely for SNP detection \[[@pone.0175969.ref015]\]. The allele-specific primers are SNP specific at the 3'end and a single base mismatch at the ante-penultimate (-3) position enhances the SNP discrimination capacity of the assay. A 15-20bp GC-clamp is added at the 5'end to one of the allele-specific primers which increases the melting temperature (T~m~) and the size of the resulting PCR product. The difference between the T~m~ and the product size is detectable by fluorescent dye on a real-time PCR platform (melt-MAMA) or by 3% agarose gel electrophoresis (agarose-MAMA), respectively.

In the current study melt- and agarose-MAMAs were developed to identify the point mutation at nt11 in the HIT family protein coding gene of *M*. *synoviae* (GenBank Accession Number: CP011096, region (complement): 195625--195945). Genome location, primer sequences, annealing and melting temperatures for the assays and PCR product sizes can be found in [Table 2](#pone.0175969.t002){ref-type="table"}. The assays were optimised by altering primer ratios \[[@pone.0175969.ref015]\]. The MAMAs were designed to be used concurrently with the previously described MS-H1 and MS-H2 melt- and agarose-MAMAs \[[@pone.0175969.ref012]\].

10.1371/journal.pone.0175969.t002

###### SNP locations in the HIT family protein coding gene, SNP state, primer sequences, primer volumes, annealing temperature (T~a~), melting temperatures (T~m~) and PCR product sizes for the MS1 melt- and agarose-MAMAs.

![](pone.0175969.t002){#pone.0175969.t002g}

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  SNP position   SNP state                       MAMA primer names   MAMA primer sequences                           Primer (10 pmol/μl) volume in 10 μl reaction mixture (μl)   T~a~ (°C)   T~m~ in °C (95% CI)   Product size (bp)   
  -------------- ------------------------------- ------------------- ----------------------------------------------- ----------------------------------------------------------- ----------- --------------------- ------------------- ----
  11             C/A                             MS1                 `ggggcggggcggggcgATTTTGTTGCAAAATAATGGAAAAcTa`   0.150                                                       1           58                    79.1\               83
                                                                                                                                                                                                                   (78.9--79.3)        

  MSW            `ATTTTGTTGCAAAATAATGGAAAAtTC`   0.150               8                                               73.5\                                                       67                                                    
                                                                                                                     (73.3--73.8)                                                                                                      

  MSR            `TTTCAGCTGGCAACTCGCG`           0.150               1                                                                                                                                                                 
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Melt-MAMA PCR reactions were performed in 10 μl total volume, containing 1μl target DNA diluted in 2 μl 5X Color-less GoTaq Flexi Buffer (Promega), 1 μl MgCl~2~ (25mM), 0.3 μl dNTP (10 mM, Qiagen), 0.5 μl EvaGreen (Biotium Inc., Hayward, CA), primers (10 pmol/μl) according to [Table 1](#pone.0175969.t001){ref-type="table"} and 0.08 μl GoTaq DNA polymerase (5 U/μl; Promega). Melt-MAMAs were carried out on an Applied Biosystems Step-One Plus real-time PCR system with StepOne Software^TM^ v2.2.2 and on Qiagen Rotor-Gene Q real-time PCR system, software version 2.3.1. Thermocycling parameters were 95°C for 10 min, followed by 39 cycles of 95°C for 15 sec and 58°C for 1 min and a dissociation protocol comprising 95°C for 15 sec, followed by incremental temperature ramping (0.2°C) from 58°C to 95°C. EvaGreen fluorescent intensity was measured at 525 nm at each ramp interval and plotted against temperature.

Agarose-MAMA PCR reaction mixtures contained 2 μl target DNA diluted in 5 μl 5X Green GoTaq Flexi Buffer (Promega), 2.5 μl MgCl~2~ (25mM), 0.5 μl dNTP (10 mM, Qiagen), primers (10 pmol/μl) according to [Table 1](#pone.0175969.t001){ref-type="table"} and 0.25 μl GoTaq DNA polymerase (5 U/μl; Promega). Agarose-MAMAs were performed in a C1000™ Touch Thermal Cycler (Bio-Rad Laboratories, Inc., Berkeley, CA, USA). Thermocycling parameters for the agarose-MAMA were 94°C for 5 min, followed by 40 cycles at 94°C for 30 sec, 58°C for 30 sec and 72°C for 30 sec with a final elongation step at 72°C for 5 min. Electrophoresis was performed in 3% agarose gel (MetaPhor Agarose, Lonza Group) and a 20-bp DNA ladder (O\'Range Ruler 20 bp, Thermo Fisher Scientific Inc.) was used as molecular weight marker.

Validation of mismatch amplification mutation assays {#sec006}
----------------------------------------------------

In order to test the intra-run repeatability at least four replicates of the two genotypes (wild-type and MS1 vaccine-type) were examined within the same run. For inter-run reproducibility test, the duplicate of at least ten samples from each genotype was examined in separate tests.

In order to test the sensitivity of the assays, 10 fold dilutions in replicates of four of the MS1 vaccine and *M*. *synoviae* type strain (WVU 1853, ATCC 25204, NCTC 10124) were used ([Fig 2](#pone.0175969.g002){ref-type="fig"}). Template copy number of the strains was calculated from the amount of DNA using the online tool developed by Staroscik \[[@pone.0175969.ref016]\]. The specificity of the assays was tested by including the following avian *Mycoplasma* species in the analysis: *M*. *anatis*, *M*. *anseris*, *M*. *cloacale*, *M*. *columbinasale*, *M*. *columborale*, *M*. *gallinaceum*, *M*. *gallinarum*, *M*. *gallisepticum*, *M*. *gallopavonis*, *M*. *iners*, *M*. *iowae*, *M*. *meleagridis* and *M*. sp. 1220. Also, the assays were performed on clinical samples originating from *M*. *synoviae* vaccinated and infected animals. The assays were considered valid if both allelic DNA templates were genotyped accurately and consistently under the same conditions \[[@pone.0175969.ref015]\].

![Amplification plot, melting-curves and PCR product sizes of MS1 melt- and agarose-MAMAs.\
Amplification plot (**A**) of dilution series of the MS1 vaccine strain (blue lines) and the *M*. *synoviae* type strain (WVU 1853, ATCC 25204, NCTC 10124; orange lines) showing the sensitivity of the assay. Green line represents negative control. Melting curves (**B**) show melting temperatures for the MS1 vaccine strain (T~m~: 79.3°C; blue line) and wild-type or MS-H vaccine strain (T~m~: 73.6°C; orange line). Electrophoresis (**C**) was performed in 3% agarose gel (MetaPhor Agarose, Lonza Group Ltd., Basel, Switzerland) and a 20-bp DNA ladder (O\'Range Ruler 20 bp, Thermo Fisher Scientific Inc.) was used as molecular weight marker (m). The MS1 vaccine strain (MS1) yielded 83 bp fragment, while the wild-type or MS-H vaccine strain (Wt) produced 67 bp fragments.](pone.0175969.g002){#pone.0175969.g002}

Results {#sec007}
=======

The developed melt- and agarose-MAMAs clearly identified the A-C polymorphism at the nt11 of the HIT family protein coding gene, distinguishing the wild, virulent *M*. *synoviae* strains and the MS-H vaccine strain from the MS1 vaccine strain, respectively. Due to the GC-clamp at the 5' end of the primer specific for the MS1 vaccine strain genotype, the melting temperature in the melt-MAMA for the MS1 vaccine genotype (T~m~: 79.1°C, CI95: 78.9--79.3°C on Step-One system and 79.3°C, CI95: 79.2--79.5°C on Rotor-Gene system) is higher by approximately 5°C than for the wild-type or MS-H vaccine genotype (T~m~: 73.5°C, CI95: 73.3--73.8°C on Step-One system and 74°C, CI95: 73.9--74.2°C on Rotor-Gene system). For the same reason, the PCR product size in the agarose-MAMA for the MS1 vaccine genotype (83 bp) is longer by 16 bp than for the wild-type or MS-H vaccine genotype (67 bp) ([Table 2](#pone.0175969.t002){ref-type="table"}, [Fig 2](#pone.0175969.g002){ref-type="fig"}).

Consistent allele calls were observed by melt-MAMA until as low as 10^2^ template number displaying a Ct range of 31--35. Negative controls or templates of other avian *Mycoplasma* species either were not amplified or generated non-specific products (with Ct above 37) with melt-profiles differing from the profiles of the expected two allelic states. Similarly, agarose-MAMAs worked reliable on samples containing 10^2^ template number and neither of the tested other avian *Mycoplasma* species caused cross-reaction (no amplicons observed). The *M*. *synoviae* type strain (WVU 1835, ATCC 25204, NCTC 10124), the ts^+^ MS-H vaccine strain (Vaxsafe® MS-H), the ts^-^ MS-H re-isolate, the 26 clinical *M*. *synoviae* isolates, the two tissue samples, the two FTA cards and the 11 DNA pools from the trachea swabs taken from clinically infected chickens and turkeys showed the wild-type strain profile while the MS1 vaccine strain (Nobilis® MS Live) and the 32 DNA pools from the trachea swabs taken from vaccinated chickens showed the MS1 vaccine strain profile in the melt- and agarose-MAMAs ([Table 1](#pone.0175969.t001){ref-type="table"}). The results were confirmed by sequencing of the HIT family protein coding gene of these samples (data not shown).

Discussion {#sec008}
==========

*M*. *synoviae* has great impact on the poultry industry and vaccination is a feasible and cost effective option to reduce economic losses. However, the differentiation of infected from vaccinated animals (DIVA) is crucial in the vaccination programs, animal trading and eradication programs.

The live, attenuated vaccine strains currently available against *M*. *synoviae* are the ts^+^ MS-H vaccine (Vaxsafe® MS-H) and the MS1 vaccine (Nobilis® MS Live) strains. The MS-H vaccine strain was developed by chemical mutagenesis and the discriminatory phenotypic characteristic of this strain is its temperature sensitivity \[[@pone.0175969.ref008]\]. The MS1 vaccine strain has been commercially released recently, it was obtained by spontaneous mutation during *in vitro* passages and it does not require NAD for its growth \[[@pone.0175969.ref009]\]. The re-isolation of the vaccine strains and the examination of the phenotypic characteristics are time-consuming \[[@pone.0175969.ref017]\]. Genotyping based on the *vlhA* gene is used worldwide for the molecular differentiation of *M*. *synoviae* strains, but this method was proved to be unreliable in the discrimination of the MS-H vaccine strain \[[@pone.0175969.ref011],[@pone.0175969.ref018]--[@pone.0175969.ref019]\]. High resolution melt-curve analysis based assay was developed to identify specific SNPs in the *obg* gene in order to distinguish the ts^+^ MS-H vaccine strain from its ts^-^ re-isolates and field strains \[[@pone.0175969.ref011]\]. In our previous study, the MS-H1 and MS-H2 MAMAs were designed to differentiate the SNPs in the *obg* gene to enable rapid, simple and cost efficient detection of the MS-H vaccine strain \[[@pone.0175969.ref012]\]. The purpose of the current study was to develop a DIVA-test for the recently released MS1 vaccine strain, which can be applied simultaneously with the assays used for the differentiation of the MS-H vaccine strain. Thus melt- and agarose-MAMAs were designed to identify the SNP at the nt11 in the HIT family protein coding gene with the same thermocycling profile as the MS-H1 and MS-H2 assays. The developed assay provides a reliable tool in routine diagnostics for the differentiation of the MS1 strain, as it is a sensitive and specific test and it can be performed directly on the clinical samples and in laboratories even with basic real-time PCR or conventional PCR equipment. The MS1 and MS-H vaccine strain specific MAMAs could efficiently support control programs against *M*. *synoviae* infections in one rapid, convenient and cost efficient step.

The strains originating from Slovenia and USA were kindly provided by Dušan Benčina.
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